Bill > SB473

This bill requires health care service plans and health insurance policies issued, amended, delivered, or renewed on or after January 1, 2023, to cover all available dosage forms and concentrations of at least one insulin product of each insulin type (rapid-acting, short-acting, intermediate-acting, or long-acting) with a copayment not exceeding $35 for a monthly supply, or a multiple of $35 for a multimonth supply. The bill also prohibits these plans and policies from imposing any other cost-sharing requirements, such as deductibles or coinsurance, on covered insulin prescriptions. Additionally, the bill prohibits these plans and policies from imposing a deductible requirement on benefits related to managing and treating diabetes.

Budget and Finance, Health and Social Services

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202120220SB473